Intratumoral administration of IL2- and TNF-based fusion proteins cures cancer without establishing protective immunity

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Barbara Ziffels, Francesca Pretto, Dario Neri

Journal title: Immunotherapy

Journal number: 10/3

Journal publisher: Future Medicine Ltd.

Published year: 2018

Published pages: 177-188

DOI identifier: 10.2217/imt-2017-0119

ISSN: 1750-743X